Literature DB >> 19545647

Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markers.

Sedigheh Zakeri1, Ahmad Raeisi, Mandana Afsharpad, Qutbuddin Kakar, Faezeh Ghasemi, Hoda Atta, Ghasem Zamani, Muhammad Suleiman Memon, Masoud Salehi, Navid Dinparast Djadid.   

Abstract

In this study, the diversity of Plasmodium vivax populations circulating in Pakistan and Iran has been investigated by using circumsporozoite protein (csp) and merozoite surface proteins 1 and 3alpha (msp-1 and msp-3alpha) genes as genetic markers. Infected P. vivax blood samples were collected from Pakistan (n=187) and Iran (n=150) during April to October 2008, and were analyzed using nested-PCR/RFLP and sequencing methods. Genotyping pvmsp-1 (variable block 5) revealed the presence of type 1, type 2 and recombinant type 3 allelic variants, with type 1 predominant, in both study areas. The sequence analysis of 33 P. vivax isolates from Pakistan and 30 from Iran identified 16 distinct alleles each, with one allele (R-8) from Iran which was not reported previously. Genotyping pvcsp gene also showed that VK210 type is predominant in both countries. Moreover, based on the size of amplified fragment of pvmsp-3alpha, three major types: type A (1800bp), type B (1500bp) and type C (1200bp), were distinguished among the examined isolates that type A was predominant among Pakistani (72.7%) and Iranian (77.3%) parasites. PCR/RFLP products of pvmsp-3alpha with HhaI and AluI have detected 40 and 39 distinct variants among Pakistani and Iranian examined isolates, respectively. Based on these three studied genes, the rate of combined multiple genotypes were 30% and 24.6% for Pakistani and Iranian P. vivax isolates, respectively. These results indicate an extensive diversity in the P. vivax populations in both studies. Copyright 2009. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545647     DOI: 10.1016/j.parint.2009.06.006

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  27 in total

1.  Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes.

Authors:  Neekesh V Dharia; A Taylor Bright; Scott J Westenberger; S Whitney Barnes; Serge Batalov; Kelli Kuhen; Rachel Borboa; Glenn C Federe; Colleen M McClean; Joseph M Vinetz; Victor Neyra; Alejandro Llanos-Cuentas; John W Barnwell; John R Walker; Elizabeth A Winzeler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-29       Impact factor: 11.205

2.  Limited polymorphism of the Plasmodium vivax merozoite surface protein 1 gene in isolates from Turkey.

Authors:  Fadile Yildiz Zeyrek; Shin-Ichiro Tachibana; Fehmi Yuksel; Nebiye Doni; Nirianne Palacpac; Nobuko Arisue; Toshihiro Horii; Cevayir Coban; Kazuyuki Tanabe
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

3.  High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea.

Authors:  Cara N Henry-Halldin; Daphne Sepe; Melinda Susapu; David T McNamara; Moses Bockarie; Christopher L King; Peter A Zimmerman
Journal:  Infect Genet Evol       Date:  2010-12-13       Impact factor: 3.342

4.  Genetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of Pakistan.

Authors:  Lubna Khatoon; Frederick N Baliraine; Mariangela Bonizzoni; Salman A Malik; Guiyun Yan
Journal:  Malar J       Date:  2010-04-23       Impact factor: 2.979

Review 5.  Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination.

Authors:  Alicia Arnott; Alyssa E Barry; John C Reeder
Journal:  Malar J       Date:  2012-01-10       Impact factor: 2.979

6.  Genetic diversity of Plasmodium vivax in clinical isolates from Bangladesh.

Authors:  Mohammad Golam Kibria; Rubayet Elahi; Abu Naser Mohon; Wasif A Khan; Rashidul Haque; Mohammad Shafiul Alam
Journal:  Malar J       Date:  2015-07-11       Impact factor: 2.979

7.  Genetic diversity of Plasmodium vivax clinical isolates from southern Pakistan using pvcsp and pvmsp1 genetic markers.

Authors:  Afsheen Raza; Najia K Ghanchi; Ali M Thaver; Sana Jafri; Mohammad A Beg
Journal:  Malar J       Date:  2013-01-11       Impact factor: 2.979

8.  Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras.

Authors:  Ana Cecilia Lopez; Andres Ortiz; Jorge Coello; Wilfredo Sosa-Ochoa; Rosa E Mejia Torres; Engels I Banegas; Irina Jovel; Gustavo A Fontecha
Journal:  Malar J       Date:  2012-11-26       Impact factor: 2.979

9.  Merozoite surface protein-3 alpha as a genetic marker for epidemiologic studies in Plasmodium vivax: a cautionary note.

Authors:  Benjamin L Rice; Mónica M Acosta; Maria Andreína Pacheco; Ananias A Escalante
Journal:  Malar J       Date:  2013-08-21       Impact factor: 2.979

10.  The unique distribution of the Plasmodium vivax merozoite surface protein 1 in parasite isolates with short and long latent periods from the Republic of Korea.

Authors:  Youn-Kyoung Goo; Jun-Hye Moon; So-Young Ji; Dong-Il Chung; Yeonchul Hong; Shin-Hyung Cho; Won-Ja Lee; Jung-Yeon Kim
Journal:  Malar J       Date:  2015-08-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.